Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:5 Issue:3 Number:51 ISSN#:2563-5476
RCT
ACE Report #8657
Ace Report Cover Sports Medicine

AAOS 2016: Liposomal bupivacaine vs femoral nerve block for postoperative ACLR pain


How to Cite

OrthoEvidence. AAOS 2016: Liposomal bupivacaine vs femoral nerve block for postoperative ACLR pain. ACE Report. 2016;5(3):51. Available from: https://myorthoevidene.com/AceReport/Report/8657

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Liposomal Bupivacaine Versus Femoral Nerve Block in Managing Pain After Anterior Cruciate Ligament Reconstruction

Contributing Authors: K Okoroha RA Keller E Jung N Mehran ET Owashi V Moutzouros

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

100 patients who underwent arthroscopic anterior cruciate ligament reconstruction (ACLR) were randomized to either intraoperative local infiltration of liposomal bupivacaine (LB) or femoral nerve block (FNB) for the management of postoperative pain. The objective of this study was to compare the effectiveness of the two treatments in postoperative pain management, opioid consumption, sleep disturb...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.